13F Filings History of Iguana Healthcare Management, LLC

Latest 13F report
Q1 2018 - 15 May 2018
Value $
$133,046,000
Signature - Title
Norman Schleifer - CFO
Location
New York, NY
Summary
This page shows a list of all the recent 13F filings made by Iguana Healthcare Management, LLC. Form 13F is required to be filed within 45 days of the end of a calendar quarter. Iguana Healthcare Management, LLC reported 59 stock holdings with total value $133,046,000 as of Q1 2018. Top holdings included ESPR, IMMU, GBT, HUM, and BIIB.

Notify me when Iguana Healthcare Management, LLC files a new 13F portfolio report.

⭐ Subscribe ⭐
Holdings Value
Quarter Holdings Value $ Bought Sold Net Top Holdings Form Type Filing Time
Q1 2018 59 $133,046,000 +$48,216,281 -$66,178,784 -$17,962,503 ESPR, IMMU, GBT, HUM, BIIB 13F-HR 15 May 2018, 16:13
Q4 2017 59 $151,447,000 +$30,171,748 -$58,172,373 -$28,000,625 ESPR, CELG, IMMU, BIIB, HUM 13F-HR 14 Feb 2018, 16:32
Q3 2017 63 $175,059,000 $0 $0 $0 CELG, ESPR, IMMU, CLVSQ, BIIB New Holdings 16 Nov 2017, 11:10
Q3 2017 63 $175,059,000 +$57,153,765 -$50,067,359 +$7,086,406 CELG, ESPR, IMMU, CLVSQ, BIIB 13F-HR 14 Nov 2017, 16:31
Q2 2017 54 $155,966,000 +$41,400,162 -$60,846,436 -$19,446,274 CELG, ALXN, CLVSQ, SHPG, AGN 13F-HR 14 Aug 2017, 17:01
Q1 2017 60 $178,928,000 +$52,774,475 -$52,708,974 +$65,501 MDCO, CELG, SHPG, AMGN, MRK 13F-HR 15 May 2017, 17:20
Q4 2016 54 $155,889,000 +$31,674,310 -$113,477,106 -$81,802,796 RARE, BIIB, MDCO, CELG, AMGN 13F-HR 14 Feb 2017, 16:06
Q3 2016 65 $251,241,000 $0 $0 $0 RARE, BIIB, SHPG, CLVSQ, ZBH New Holdings 17 Nov 2016, 15:36
Q3 2016 65 $251,241,000 +$74,698,338 -$72,403,782 +$2,294,556 RARE, BIIB, SHPG, CLVSQ, ZBH 13F-HR 14 Nov 2016, 17:03
Q2 2016 69 $217,148,000 +$81,729,952 -$92,715,322 -$10,985,370 CELG, ZBH, GILD, SHPG, ELV Restatement 04 Nov 2016, 16:05
Q1 2016 59 $213,945,000 +$96,643,476 -$105,789,527 -$9,146,051 CELG, CI, MDVN, BAX, ZBH Restatement 24 May 2016, 13:24
Q4 2015 59 $260,444,000 +$119,824,399 -$84,839,972 +$34,984,427 CELG, CI, AMGN, RARE, BAX 13F-HR 16 Feb 2016, 16:23
Q3 2015 61 $212,862,000 +$70,565,307 -$61,032,412 +$9,532,895 ELV, VRX, RARE, GILD, CELG 13F-HR 16 Nov 2015, 16:14
Q2 2015 54 $246,308,000 +$102,511,760 -$102,831,973 -$320,213 RARE, CELG, ESPR, GILD, AMGN 13F-HR 14 Aug 2015, 16:28
Q1 2015 62 $235,405,000 +$124,246,679 -$84,124,639 +$40,122,040 PFE, ESPR, CELG, RARE, GILD Restatement 10 Jun 2015, 13:48
Q4 2014 48 $180,915,000 +$46,155,276 -$50,425,756 -$4,270,480 BIIB, CELG, GILD, MDT, XLRN 13F-HR 17 Feb 2015, 19:10
Q3 2014 51 $165,728,000 +$50,732,819 -$59,083,274 -$8,350,455 BIIB, GILD, AMGN, MDT, ABBV 13F-HR 14 Nov 2014, 16:39
Q2 2014 50 $165,864,000 +$56,323,084 -$52,800,814 +$3,522,270 BIIB, AMGN, MDT, CELG, MRK 13F-HR 14 Aug 2014, 16:17
Q1 2014 50 $159,605,000 +$63,936,934 -$38,141,194 +$25,795,740 BIIB, AMGN, MRK, CI, ZBH 13F-HR 16 May 2014, 12:55
Q4 2013 52 $129,567,000 $0 $0 $0 AMGN, MRK, BIIB, ZBH, GILD 13F-HR 14 Feb 2014, 16:43